# General Decolonization With Octenisan® Set Before Elective Orthopedic Surgery

> **NCT05647252** · PHASE3 · COMPLETED · sponsor: **Balgrist University Hospital** · enrollment: 1086 (actual)

## Conditions studied

- Elective Surgery
- High Risk
- Prevention of Surgical Site Infections
- Randomized-controlled Trial

## Interventions

- **DRUG:** Whole Body and nasal decolonization with octenidin (Octenisan Set)
- **BEHAVIORAL:** Questionnaire for study participants immediately after the decolonization

## Key facts

- **NCT ID:** NCT05647252
- **Lead sponsor:** Balgrist University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-27
- **Primary completion:** 2024-11-28
- **Final completion:** 2025-02-20
- **Target enrollment:** 1086 (ACTUAL)
- **Last updated:** 2025-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05647252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05647252, "General Decolonization With Octenisan® Set Before Elective Orthopedic Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05647252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*